Global Hemp Group Inc. Stock

Equities

GHG

CA37953Y2033

Healthcare Facilities & Services

Delayed Canadian Securities Exchange 15:57:07 2024-04-15 EDT 5-day change 1st Jan Change
0.045 CAD -25.00% Intraday chart for Global Hemp Group Inc. -.--% -30.77%
Sales 2021 - Sales 2022 - Capitalization 5.04M 6.89M
Net income 2021 -8M -10.94M Net income 2022 -2M -2.74M EV / Sales 2021 -
Net Debt 2021 4.06M 5.55M Net Debt 2022 2.89M 3.96M EV / Sales 2022 -
P/E ratio 2021
-1.16 x
P/E ratio 2022
-2.15 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 90.37%
More Fundamentals * Assessed data
Dynamic Chart
1 day-25.00%
Current month-10.00%
1 month-10.00%
3 months-10.00%
6 months+80.00%
Current year-30.77%
More quotes
1 month
0.05
Extreme 0.045
0.06
Current year
0.05
Extreme 0.045
0.12
1 year
0.02
Extreme 0.015
0.20
3 years
0.02
Extreme 0.015
2.20
5 years
0.02
Extreme 0.015
2.20
10 years
0.02
Extreme 0.015
7.80
More quotes
Managers TitleAgeSince
Chief Executive Officer - 14-11-16
Chief Tech/Sci/R&D Officer 64 -
Corporate Secretary 50 20-05-20
Members of the board TitleAgeSince
Chief Executive Officer - 14-11-16
Director/Board Member - 23-02-13
Corporate Secretary 50 20-05-20
More insiders
Global Hemp Group Inc. is a Canada-based company, which is focused on developing and promoting hemp-based products. The Company operates through two segments: BioPharma Division and Industrial Hemp Division. BioPharma Division has executed a Letter of Intent (LOI) with B-Organic R&D Corp. (B-Organic) to license its Bioactive Lipid Agents (BLA) technology, a patented matrix, which is able to increase the solubility and bioavailability of various poorly soluble pharma ingredients, including cannabinoids. Industrial Hemp Division is involved in the development and promotion of hemp-based products. The Company’s has acquired the perpetual license for North America (the United States, Canada and Mexico) to certain Apollon Intellectual Property and proprietary technology.
More about the company